Bowhead Specialty (NYSE:BOW - Get Free Report) is anticipated to announce its Q2 2025 earnings results before the market opens on Tuesday, August 5th. Analysts expect the company to announce earnings of $0.37 per share and revenue of $134.66 million for the quarter.
Bowhead Specialty (NYSE:BOW - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported $0.34 EPS for the quarter, beating the consensus estimate of $0.33 by $0.01. The firm had revenue of $174.85 million for the quarter, compared to analyst estimates of $105.17 million. Bowhead Specialty had a net margin of 9.32% and a return on equity of 12.52%. On average, analysts expect Bowhead Specialty to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Bowhead Specialty Trading Down 1.9%
NYSE:BOW traded down $0.61 during mid-day trading on Friday, hitting $31.89. 130,799 shares of the company's stock were exchanged, compared to its average volume of 167,235. The company has a 50 day simple moving average of $35.24 and a 200-day simple moving average of $36.02. Bowhead Specialty has a fifty-two week low of $24.80 and a fifty-two week high of $42.29. The firm has a market capitalization of $1.05 billion, a P/E ratio of 24.34 and a beta of -0.68.
Wall Street Analysts Forecast Growth
BOW has been the subject of a number of analyst reports. Morgan Stanley lifted their price objective on shares of Bowhead Specialty from $36.00 to $39.00 and gave the company an "equal weight" rating in a report on Monday, May 19th. Piper Sandler started coverage on shares of Bowhead Specialty in a research note on Wednesday, April 16th. They issued an "overweight" rating and a $44.00 target price for the company. JMP Securities increased their price target on shares of Bowhead Specialty from $38.00 to $40.00 and gave the company a "market outperform" rating in a research report on Friday, April 11th. JPMorgan Chase & Co. increased their price target on shares of Bowhead Specialty from $30.00 to $35.00 and gave the company a "neutral" rating in a research report on Tuesday, April 8th. Finally, Keefe, Bruyette & Woods increased their price target on shares of Bowhead Specialty from $43.00 to $45.00 and gave the company an "outperform" rating in a research report on Friday, May 9th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $39.67.
View Our Latest Report on Bowhead Specialty
Institutional Investors Weigh In On Bowhead Specialty
A number of institutional investors and hedge funds have recently bought and sold shares of BOW. Royal Bank of Canada raised its stake in Bowhead Specialty by 112.7% in the first quarter. Royal Bank of Canada now owns 5,406 shares of the company's stock valued at $219,000 after purchasing an additional 2,864 shares in the last quarter. AQR Capital Management LLC purchased a new stake in Bowhead Specialty in the first quarter valued at approximately $430,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Bowhead Specialty by 42.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,389 shares of the company's stock worth $382,000 after acquiring an additional 2,802 shares in the last quarter. Millennium Management LLC raised its stake in shares of Bowhead Specialty by 75.8% during the first quarter. Millennium Management LLC now owns 250,277 shares of the company's stock worth $10,174,000 after acquiring an additional 107,896 shares in the last quarter. Finally, NewEdge Advisors LLC purchased a new position in shares of Bowhead Specialty during the first quarter worth approximately $206,000.
About Bowhead Specialty
(
Get Free Report)
Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
See Also
Before you consider Bowhead Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.
While Bowhead Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.